Department of Animal Science
Date of this Version
11-23-2021
Citation
Patent No .: US 11,178,859 B2
Abstract
The present disclosure provides compositions and methods for increasing resistance to PCV2 infection in pigs. The increased resistance may be the result of siRNA or genetic modification through CRISPR or a vectored virus targeting SNPs that are resistant to PCV2 infection.